Beauty Health (SKIN)
1.31
-0.05 (-3.68%)
At close: Mar 28, 2025, 3:57 PM
1.32
0.01%
Pre-market: Mar 31, 2025, 07:00 AM EDT
Beauty Health Revenue Breakdown
Quarter | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Consumables Revenue | 51.19M | 45.62M | 98.55M | 51.89M | 40.92M | 47.42M | 39.7M | 38.75M | 33.77M | 35.22M | 31.96M | 31.56M |
Consumables Revenue Growth | +12.21% | -53.71% | +89.92% | +26.79% | -13.70% | +19.46% | +2.44% | +14.76% | -4.13% | +10.19% | +1.27% | n/a |
Delivery Systems Revenue | 27.61M | 35.78M | 95.69M | 65.59M | 45.35M | 50.71M | 49.09M | 64.78M | 41.65M | 42.67M | 36.18M | 34.94M |
Delivery Systems Revenue Growth | -22.83% | -62.60% | +45.89% | +44.62% | -10.57% | +3.29% | -24.22% | +55.55% | -2.39% | +17.92% | +3.54% | n/a |
Revenue by Geography
Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
---|---|---|---|
Asia Pacific Revenue | 82.19M | 54.31M | 43.7M |
Asia Pacific Revenue Growth | +51.35% | +24.27% | n/a |
Emea Revenue | 88.09M | 68.33M | 46.96M |
Emea Revenue Growth | +28.92% | +45.50% | n/a |
United States Revenue | 227.71M | 243.24M | 169.43M |
United States Revenue Growth | -6.39% | +43.57% | n/a |
Operating Expense Breakdown
Quarter | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 61.06M | 61.89M | 62.55M | 61M | 67.7M | 78.1M | 69.1M | 67.49M | 63.55M | 72.47M | 62.67M | 62.1M | 49.65M | 70.62M | 27.91M | 26.89M | 17.59M | 11.6M | 24.89M | 23.32M |
Selling, General, and Administrative Revenue Growth | -1.35% | -1.04% | +2.53% | -9.90% | -13.32% | +13.02% | +2.38% | +6.21% | -12.31% | +15.63% | +0.92% | +25.07% | -29.69% | +153.05% | +3.79% | +52.82% | +51.71% | -53.40% | +6.73% | n/a |
Research and Development Revenue | 1.11M | 1.16M | 2.81M | 3M | 1.8M | 2.9M | 2.3M | 1.45M | 2.17M | 2.6M | 2.23M | 1.88M | 1.88M | 2.99M | 1.45M | 860K | 577K | 597K | 1.38M | 1.25M |
Research and Development Revenue Growth | -4.40% | -58.71% | -6.43% | +66.67% | -37.93% | +26.09% | +59.06% | -33.27% | -16.69% | +16.64% | +18.93% | -0.27% | -37.08% | +105.79% | +68.84% | +49.05% | -3.35% | -56.61% | +9.90% | n/a |
Sales and Marketing Revenue | 27.62M | 30.48M | 33.68M | 32.02M | 30.7M | 43M | 38.7M | 39.02M | 39.77M | 44.88M | 36.41M | 37.05M | 30.45M | 26.21M | 17.09M | 15.9M | 10.54M | 6.19M | 17.7M | 16.81M |
Sales and Marketing Revenue Growth | -9.39% | -9.51% | +5.18% | +4.32% | -28.60% | +11.11% | -0.82% | -1.88% | -11.39% | +23.28% | -1.74% | +21.68% | +16.16% | +53.34% | +7.53% | +50.82% | +70.40% | -65.04% | +5.30% | n/a |